After completing combined M.D., Ph.D. training at Tufts University, Gary D. Hammer, M.D., Ph.D. completed his residency in Internal Medicine, fellowship in Endocrinology and a post-doctoral fellowship at University of California-San Francisco. Dr. Hammer joined the faculty at University of Michigan in 1999 as an Assistant Professor, was promoted to Associate Professor in 2005, and became a full Professor in 2011. Dr. Hammer currently serves as the Director of the Endocrine Oncology Program in the Comprehensive Cancer Center at UM where he holds the Millie Schembechler Professorship in Adrenal Cancer. The Program is considered a worldwide leader in endocrine cancers - exemplified by its recent leadership role in 3 recent platforms of the NCI TCGA (papillary thyroid cancer, adrenocortical carcinoma and pheochromocytoma). Specifically, the Program is uniquely recognized an international center of excellence for research and treatment of adrenal cancer. Dr. Hammer is best recognized for his research in adrenal homeostasis and neoplasia and for the treatment of adrenal cancer. He has received the UM Jerome Conn Award for Outstanding Research in Internal Medicine, the Endocrine Society Edwin B. Astwood Award for Outstanding Research in Endocrinology and is a member of American Society for Clinical Investigation and Association of American Physicians. He is the editor of three textbooks: Adrenocortical Carcinoma: Basic Science and Clinical Concepts (Springer 2011), Pathophysiology of Disease: An Introduction to Clinical Medicine (Harper Row, 2018) and Genetics of Steroid Disorders (Elsevier, 2014). He has served in numerous capacities across the tripartite constituencies of the Endocrine Society including Overall Chair of the 2017 Annual Meeting, Chair of the Student Affairs Committee, Chair of the Mentoring Task Force, Basic Science Chair of Trainee Day at Annual Meeting, Council Member at Large and a Society Ambassador to King Edward Memorial Hospital in Mumbai India as part of the inaugural Endocrine Society Ambassador Exchange Program. Hammer's own laboratory has focused on 1) defining stem/progenitor cells and critical signaling/transcriptional programs that dictate cell fate, self-renewal, multi potency in health and disease; 2) directing landmark genetic/genomic studies in adrenal neoplasia/cancer; and 3) leveraging critical cellular pathways to launch ongoing international clinical adrenal trials with newly-developed targeted therapeutics. Most recently, Dr. Hammer cofounded Millendo biotechnology company focusing on therapies for adrenal cancer and other related endocrine diseases of steroid excess. With UofM colleagues he also has formed the American Australian ASIAN ALLIANCE (A5) that aims to facilitate and leverage international collaboration for adrenal disease.

Dr. Young is Professor of Medicine in the Mayo Clinic College of Medicine. As Chair of the Division of Endocrinology at Mayo Clinic he leads one of the largest endocrine departments in the world. He is a Past President of the Endocrine Society and is the current Chair of the American Board of Internal Medicine Specialty Board in Endocrinology. Dr. Young has published over 250 articles on endocrine hypertension and adrenal and pituitary disorders. He has been the recipient of multiple education awards and has presented at over 500 national and international meetings.

Paul Stewart is the Executive Dean of the Faculty of Medicine & Health and Dean of the Medical School at the University of Leeds. He is a Non-Executive Director and an Honorary Consultant Endocrinologist at the Leeds Teaching Hospitals NHS Trust. He received his medical degree from Edinburgh Medical School in 1982 and was awarded an MD from Edinburgh University with Honours and a Gold Medal in 1988. Professor Stewart's clinical expertise includes the management of pituitary and adrenal disorders, endocrine hypertension and reproductive medicine. He is a primary investigator within the National Institute for Health Research (NIHR) Musculoskeletal Biomedical Research Unit in Leeds, an NIHR Senior Clinical Investigator and his research has been funded by MRC, Wellcome Trust and ERC. Professor Stewart has served as General Secretary to the Society for Endocrinology and is Secretary-Treasurer to the International Society of Endocrinology. He chairs the Chairs & Programme Grants Committee of the British Heart Foundation, and is Vice-President of the Academy of Medical Sciences. Professor Stewart is formerly a Member of the MRC Strategy Board and Chair of the MRC Careers and Training Committee. He has authored over 300 original peer-reviewed publications and has delivered numerous prize lectures to specialist societies, including the Royal College of Physicians Linacre, Goulstonian and Simms Lectures, the Society for Endocrinology Medal Lecture, the Clinical Endocrinology Trust Medal Lecture, the Dale medal lecture, the European Journal of Endocrinology Prize Lecture, Sir George Pickering Medal, and the Clinical Investigator Award from The Endocrine Society.